Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N8RD
|
||||
Former ID |
DNC003371
|
||||
Drug Name |
N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551393] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H21N3O3S
|
||||
Canonical SMILES |
CCC(CNC(=O)C1=CC=C(C=C1)S(=O)(=O)N)C2=CC3=C(C=C2)NC=C3
|
||||
InChI |
1S/C19H21N3O3S/c1-2-13(15-5-8-18-16(11-15)9-10-21-18)12-22-19(23)14-3-6-17(7-4-14)26(20,24)25/h3-11,13,21H,2,12H2,1H3,(H,22,23)(H2,20,24,25)/t13-/m1/s1
|
||||
InChIKey |
FSRPBGBMEKDSIJ-CYBMUJFWSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Carbonic anhydrase II | Target Info | Inhibitor | [551393] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
EGFR1 Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.